Simonetta Viviani, MD - DCVMN
Clarke E. et al. Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia. Lancet Global Health 2016 Jun 27.
Download Simonetta Viviani, MD - DCVMN
Information
Domain:
Source:
Link to this page:
Documents from same domain
BIOFARMA EXPERIENCE WITH ASEAN CTD - …
www.dcvmn.org•Established in Jakarta (ASEAN Secretariat), December 2016 • Guideline of the agreed upon common format for the preparation of a well-structured Common Technical Dossier
Validation and Management of Heat Sterilization - …
www.dcvmn.orgCBE – 106 V1 Module Topics How does heat sterilization work Critical process parameters and metrics Developing a validation process / cycle Bioburden reduction vs. …
TECHNIP LIFE SCIENCES - DCVMN
www.dcvmn.orgTECHNIP LIFE SCIENCES MAP Technip is present throughout different centers in the word ... Risk Management approach for your existing facilities,
Regulatory Basics for Facility Design (WHO GMP): …
www.dcvmn.orgRisk Group for Laboratory Work1 (2) 4 Risk Group Biosafety Level Laboratory Type Laboratory Practices Safety Equipment 1 Basic –BSL 1 Basic teaching, research
Aseptic Processing Practices and Process Validation of ...
www.dcvmn.orgCBE – 107 V1 How do we make sterile products ? There are two main approaches used in our industry Terminal sterilization – where the final filled product is sterilized (e.g. in an autoclave or by irradiation.) Media Fill is not required. Option not availabe lfor
04 qualification and validation overview - DCVMN
www.dcvmn.orgMay 2015, page 9 Common understanding of the GEP and GMP Regulations " Qualification and Validation activities are needed to achieve the target of reliable product quality and safe products! • ISPE Baseline, Vol. 5, Commissioning and Qualification, 2001 • GAMP 5 (Computerized Systems) • ASTM E2500-7, Standard Guide for Specification, Design, and Verification of
General Introduction to GMP, History, ICH, PIC/S, EU, FDA
www.dcvmn.org© Pharmaceutical Consultancy Services, All rights reserved. General Introduction to GMP, History, ICH, PIC/S, EU, FDA
Microbiology Controls Environmental Monitoring Programs
www.dcvmn.orgEnvironmental Monitoring of Clean Rooms in Vaccine Facilities Points to consider for manufacturers of human vaccines EM describes the microbiological testing undertaken in order to detect changing trends of microbial counts and micro-flora …
How To Establish Sample Sizes For Process Validation …
www.dcvmn.orgHow To Establish Sample Sizes For Process Validation Using The Success-Run Theorem By Mark Durivage, ASQ Fellow The first article in this series, Risk-Based Approaches To Establishing Sample Sizes For Process Validation (June 2016), provided and established the relationship between risk and sample size. This installment will demonstrate
Critical Quality Attributes, Critical Process Parameters ...
www.dcvmn.orgCritical Quality Attributes, Critical Process Parameters, Tracking and Trending Rajesh K. Gupta, Ph.D. Biologics Quality & Regulatory Consultants, LLC Analyze, Strategize & Operate – Different & Smart rgupta@bqrc.org 1 240 246 0126 DCVMN Training Workshop – Hyderabad, India April 4 – 8, 2016 Biologics Quality & Regulatory Consultants, LLC
Related documents
Vaccine safety and the management of adverse events ...
assets.publishing.service.gov.ukreactions will vary according to the characteristics of the vaccine received, the age of the recipient and the biological response to that vaccine. For example, fever may start within a few hours of tetanus- containing vaccines, but occurs seven to ten days after measles- containing vaccine. The occurrence of such systemic reactions does not
Vaccination of the egg-allergic individual
www.allergy.org.au1 Vaccination of the egg-allergic individual Summary • Egg allergic individuals may be safely vaccinated with the measles mumps rubella (MMR), the measles mumps rubella varicella (MMR-V) vaccine (which contains no egg protein) and the influenza vaccine (which may contain minute traces of egg protein).
Chapter 13: Measles; Epidemiology and Prevention of ...
www.cdc.govfewer reactions than the original Edmonston B vaccine. In 1971, measles vaccine was licensed as a combined measles, mumps, and rubella (MMR) vaccine. In 2005, a combination measles, mumps, rubella, and varicella (MMRV) vaccine was licensed. Measles vaccine is available as measles, mumps, and rubella
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euThe physician should be aware that the rate of febrile reactions is higher when Infanrix hexa is co-administered with a pneumococcal conjugate vaccine (PCV7, PCV10, PCV13), or with a measles-mumps-rubella-varicella (MMRV) vaccine, compared to that occurring following the administration of
HIGHLIGHTS OF PRESCRIBING INFORMATION VARIVAX …
www.merck.comAt least 1 month should elapse between a dose of measles-containing vaccine and a dose of VARIVAX if the vaccines are not given concurrently [see Clinical Studies (14.1)]. ... vaccine and may not reflect the rates observed in clinical practice. Vaccine-related adverse reactions ... (p<0.05) greater rate in vaccine recipients than in placebo ...
M-M-R II (MEASLES, MUMPS, and RUBELLA VIRUS VACCINE …
www.who.intimmunized with live measles virus vaccine; no studies have been reported to date of the effect of measles virus vaccines on untreated tuberculous children. However, individuals with active untreated tuberculosis should not be vaccinated. As for any vaccine, vaccination with M-M-R II may not result in protection in 100% of vaccinees.